Cargando…
Using host receptor as a decoy to treat COVID‐19: a solution for immune escape?
There is an unmet clinical need to end the COVID‐19 pandemic. In the past 2 years, the SARS‐CoV‐2 continued to evolve and poses a critical challenge to the efficacy of the vaccine and neutralizing antibody therapies. The fifth wave of the pandemic is driven by the Omicron variants, due to their abil...
Autores principales: | Huang, Kuo‐Yen, Lin, Ming‐Shiu, Yang, Pan‐Chyr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641416/ https://www.ncbi.nlm.nih.gov/pubmed/36256519 http://dx.doi.org/10.15252/emmm.202216818 |
Ejemplares similares
-
Kawasaki disease and MIS-C share a host immune response
por: Tsoukas, Paul, et al.
Publicado: (2022) -
How the devil facial tumor disease escapes host immune responses
por: Siddle, Hannah V, et al.
Publicado: (2013) -
Telemedicine: a solution for everyone?
por: Krusche, Martin
Publicado: (2022) -
Ubiquitination of PHYTOSULFOKINE RECEPTOR1 regulates plant immunity
por: Zhang, Shiqing, et al.
Publicado: (2023) -
Cellular decoys distract coronavirus
por: Bradley, David
Publicado: (2020)